Medication info
Nexeprazole 40 mg Tablets (Esomeprazole Magnesium Trihydrate)

Nexeprazole 40 mg Tablets (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Dihydrate›43.38mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
<Domestic> 28 tablets (14 tablets/Alu-Alu * 2), <Export> 10T (10 tablets/Alu-Alu), 28 tablets (14 tablets/Alu-Alu * 2)
Approval status
Active

MFDS item code 201507948 · Approved 2015.11.26 · Insurance code 671704860

Summary

Main use
Treatment of gastroesophageal reflux disease, gastrointestinal disorders (ulcers, Helicobacter pylori, etc.), and Zollinger-Ellison syndrome
Who uses it
Adults · Children
Adult dosage
1. Adults 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Give 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist may take it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have resolved, control subsequent symptoms by taking 20 mg once daily. · Adults may take 20 mg once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Take this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Clinical studies lasting longer than 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. The treatment duration is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into two doses. 6) Maintenance therapy after induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration After induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration, give 40 mg once daily for 4 weeks. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine must not exceed 20 mg. 6. Elderly patients No dose adjustment is necessary.
Children's dosage
Adolescents 12 years of age and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Give 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist may take it for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have resolved, control subsequent symptoms by taking 20 mg once daily. Children under 12 years of age There is no experience with administration of this medicine to children under 12 years of age.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, gastrointestinal disorders (ulcers, Helicobacter pylori, etc.), and Zollinger-Ellison syndrome

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used to treat gastroesophageal reflux disease and erosive esophagitis, and it is also effective as a long-term maintenance therapy for preventing recurrence in esophagitis patients. Moreover, it helps alleviate symptoms associated with gastroesophageal reflux in patients without esophagitis. It is included in the antibiotic combination therapy for eradicating Helicobacter pylori, contributing to the prevention of recurrence in patients with duodenal ulcers and peptic ulcers who are Helicobacter pylori positive. It is also applicable for short-term therapy in the treatment of upper gastrointestinal symptoms, pain, and discomfort associated with non-steroidal anti-inflammatory drugs. Additionally, it helps in the treatment and prevention of gastric and duodenal ulcers in patients requiring continuous administration of non-steroidal anti-inflammatory drugs, and it is used in the treatment of Zollinger-Ellison syndrome. Finally, it is effective as a maintenance therapy following the prevention of rebleeding from gastric or duodenal ulcers. This medication is widely used to treat and prevent gastrointestinal diseases.

Dosage and Administration

Adult dosage

1. Adults 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Give 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist may take it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have resolved, control subsequent symptoms by taking 20 mg once daily. · Adults may take 20 mg once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Take this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Clinical studies lasting longer than 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. The treatment duration is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80 ∼ 160 mg daily. Doses greater than 80 mg daily should be divided into two doses. 6) Maintenance therapy after induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration After induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration, give 40 mg once daily for 4 weeks. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine must not exceed 20 mg. 6. Elderly patients No dose adjustment is necessary.

Children's dosage

Adolescents 12 years of age and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Give 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist may take it for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. · Once symptoms have resolved, control subsequent symptoms by taking 20 mg once daily. Children under 12 years of age There is no experience with administration of this medicine to children under 12 years of age.

Precautions

This medication should not be administered to patients allergic to specific components or benzimidazole derivatives. Caution is also required when combining this medication with patients allergic to penicillin antibiotics or macrolide antibiotics. Serious interactions may occur if this medication is taken with certain drugs (e.g., terfenadine, cisapride, pimodine, astemizole, atazanavir, nelfinavir, rilpivirine) and should be avoided. It is safest for nursing women not to take this medication. Patients with a history of myocardial infarction or currently experiencing myocardial infarction should not use this medication. Diverse side effects can occur while taking this medication, and may include headache, abdominal pain, diarrhea, skin rash, muscle pain, and rarely, serious allergic reactions or liver dysfunction. Long-term use may increase the risk of electrolyte imbalances such as hypomagnesemia or fractures; therefore, regular monitoring is necessary. This medication can increase the risk of bacterial overgrowth in the gut by suppressing gastric acid secretion; consultation with a healthcare professional is needed if diarrhea persists. There are many drug interactions, especially with medications such as warfarin, methotrexate, clopidogrel, where changes in blood concentration and side effect risks may occur; physician's instructions should be followed. The safety of this medication during pregnancy has not been established, so it should be used cautiously only when necessary. In case of overdose, there are no specific antidotes, and appropriate treatment and observation are needed according to symptoms. Keep this medication out of reach of children and store it in its original container.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, dysesthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distention, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reactions associated with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid gland enlargement, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal dysmotility, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, worsening arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, polymyositis, arthralgia, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, anxiety, sensory deficits, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disturbances, tremors, dizziness, visual field defects, dysesthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, worsening asthma, cough, shortness of breath, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, dysosmia, taste loss, taste distortion, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis, myalgia, asthenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is also suggested to keep it away from direct sunlight and store it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

<Domestic> 28 tablets (14 tablets/Alu-Alu * 2), <Export> 10T (10 tablets/Alu-Alu), 28 tablets (14 tablets/Alu-Alu * 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.